Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer

NCT03829930 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Sponsor discontinued the drug

Conditions

Prostate Adenocarcinoma

Interventions

DRUG: Entinostat
DRUG: Enzalutamide

Sponsor

George Washington University